These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 17673469

  • 1. Relationship between expression of vascular endothelial growth factor in tumor tissue from gastric cancers and chemotherapy effects: comparison between S-1 alone and the combination of S-1 plus CDDP.
    Boku N, Ohtsu A, Nagashima F, Shirao K, Koizumi W.
    Jpn J Clin Oncol; 2007 Jul; 37(7):509-14. PubMed ID: 17673469
    [Abstract] [Full Text] [Related]

  • 2. Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
    Boku N, Ohtsu A, Yoshida S, Shirao K, Shimada Y, Hyodo I, Saito H, Miyata Y, Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group (GIOSG/JCOG).
    Jpn J Clin Oncol; 2007 Apr; 37(4):275-81. PubMed ID: 17522103
    [Abstract] [Full Text] [Related]

  • 3. Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
    Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB, Yanagihara R, Phan AT, Yao JC, Strumberg D.
    J Clin Oncol; 2006 Feb 01; 24(4):663-7. PubMed ID: 16446338
    [Abstract] [Full Text] [Related]

  • 4. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W, Kurihara M, Hasegawa K, Chonan A, Kubo Y, Maekawa R, Iwasaki R, Sasai T, Fukuyama Y, Ishikawa K, Miyoshi K, Yasutake K, Hayakawa M.
    Oncol Rep; 2004 Sep 01; 12(3):557-61. PubMed ID: 15289837
    [Abstract] [Full Text] [Related]

  • 5. [Three successful case reports of advanced gastric cancer with chemotherapy].
    Yamamoto M, Niinobu T, Taniguchi H, Kotobuki T, Fukunaga K, Kawai M.
    Gan To Kagaku Ryoho; 2004 Oct 01; 31(11):1689-92. PubMed ID: 15553684
    [Abstract] [Full Text] [Related]

  • 6. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
    Koizumi W, Tanabe S, Higuchi K, Sasaki T, Nakayama N, Nagaba S, Azuma M, Shimoda T, Nishimura K, Nakatani K, Saigenji K.
    Gan To Kagaku Ryoho; 2004 Nov 01; 31(12):1957-61. PubMed ID: 15570920
    [Abstract] [Full Text] [Related]

  • 7. Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
    Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB, Strumberg D, Yanagihara R, Yao JC, Phan AT, Ajani JA.
    Cancer; 2007 Jan 01; 109(1):33-40. PubMed ID: 17133415
    [Abstract] [Full Text] [Related]

  • 8. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
    Boku N, Chin K, Hosokawa K, Ohtsu A, Tajiri H, Yoshida S, Yamao T, Kondo H, Shirao K, Shimada Y, Saito D, Hasebe T, Mukai K, Seki S, Saito H, Johnston PG.
    Clin Cancer Res; 1998 Jun 01; 4(6):1469-74. PubMed ID: 9626464
    [Abstract] [Full Text] [Related]

  • 9. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
    Fukuda H, Takiguchi N, Koda K, Oda K, Seike K, Miyazaki M.
    Cancer Invest; 2006 Jun 01; 24(3):235-41. PubMed ID: 16809149
    [Abstract] [Full Text] [Related]

  • 10. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
    Nakata B, Hirakawa K.
    Gan To Kagaku Ryoho; 2004 Nov 01; 31(12):1962-8. PubMed ID: 15570921
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.
    Ajani JA, Faust J, Ikeda K, Yao JC, Anbe H, Carr KL, Houghton M, Urrea P.
    J Clin Oncol; 2005 Oct 01; 23(28):6957-65. PubMed ID: 16145066
    [Abstract] [Full Text] [Related]

  • 13. Combined S-1 and cisplatin preoperative chemotherapy for patients with advanced gastric cancer: report of five cases.
    Nakane Y, Inoue K, Michiura T, Nakai K, Sato M, Baden T, Okumura S, Yamamichi K.
    Hepatogastroenterology; 2004 Oct 01; 51(55):289-93. PubMed ID: 15011888
    [Abstract] [Full Text] [Related]

  • 14. [S-1+Low-Dose CDDP].
    Nakata B, Tsuji A, Hirakawa K.
    Gan To Kagaku Ryoho; 2006 Jun 01; 33 Suppl 1():68-74. PubMed ID: 16897975
    [Abstract] [Full Text] [Related]

  • 15. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
    Ajani JA.
    Gan To Kagaku Ryoho; 2006 Jun 01; 33 Suppl 1():117-20. PubMed ID: 16897985
    [Abstract] [Full Text] [Related]

  • 16. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
    Wasaburo K, Tanabe S, Higuchi K, Sasaki T, Nakayama N, Mihara S, Nakatani K, Nishimura K, Shimoda T, Azuma M, Katada C, Hanaoka N, Naruke A, Ryu T, Ishido K, Saigenji K.
    Gan To Kagaku Ryoho; 2006 Jun 01; 33 Suppl 1():57-63. PubMed ID: 16897973
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
    Tsuji A, Shima Y, Morita S, Uchida M, Okamoto K, Morita M, Horimi T, Shirasaka T.
    Anticancer Res; 2008 Jun 01; 28(2B):1433-8. PubMed ID: 18505092
    [Abstract] [Full Text] [Related]

  • 18. [Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer].
    Shirasaka T, Aiba K, Araki H, Suzuki M, Terashima M, Mikami Y.
    Gan To Kagaku Ryoho; 1999 Mar 01; 26(4):456-66. PubMed ID: 10097742
    [Abstract] [Full Text] [Related]

  • 19. [Feasibility of S-1/CDDP therapy for outpatients with advanced gastric cancer].
    Rino Y, Murakami H, Yukawa N, Wada N, Oshima T, Matsuura H, Sugano N, Arai H, Masuda M, Imada T.
    Gan To Kagaku Ryoho; 2009 Nov 01; 36(11):1829-31. PubMed ID: 19920383
    [Abstract] [Full Text] [Related]

  • 20. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
    Taniwaki S, Saruwatari A, Yoshida T, Mizoguchi A, Kitasato Y, Kitamura T, Hidaka A, Shiota K, Kuroda H, Tanaka M, Higashi T, Iwanaga Y, Ogata Y.
    Gan To Kagaku Ryoho; 2009 Feb 01; 36(2):279-82. PubMed ID: 19223745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.